NCT03987217View on ClinicalTrials.gov

Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 17, 2019

Primary Completion Date

March 10, 2025

Study Completion Date

March 10, 2025

Conditions

FatigueMetastatic Prostate CarcinomaSedentary LifestyleStage IV Prostate Cancer AJCC (American Joint Committee on Cancer) v8Stage IVA Prostate Cancer AJCC (American Joint Committee on Cancer) v8Stage IVB Prostate Cancer AJCC (American Joint Committee on Cancer) v8

Interventions

DIETARY_SUPPLEMENT

Creatine Monohydrate

Given orally

BEHAVIORAL

Exercise Intervention

Complete POWER resistance training program

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

84112

Huntsman Cancer Institute/University of Utah, Salt Lake City

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Utah

OTHER

NCT03987217 - Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients | Biotech Hunter | Biotech Hunter